Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

Jefferies has recently initiated Biohaven Ltd (BHVN) stock to Buy rating, as announced on September 16, 2024, according to Finviz. Earlier, on September 4, 2024, Bernstein had initiated the stock to ...

Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...

Biohaven is accused of giving health care providers cash and lavish meals to get them to prescribe Nurtec ODT, a migraine ...